Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuele Crespan

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Nature Communications|February 27, 2016
Impact of ribonucleotide incorporation by DNA polymerases β and λ on oxidative base excision repairEmmanuele Crespan, Antonia Furrer, Marcel Rösinger, et al.
Chemmedchem|October 13, 2011
N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a scaffold for the synthesis of inhibitors of Bcr-AblFederica Arioli, Stella Borrelli, Francesco Colombo, et al.
Chemmedchem|May 31, 2022
Towards Innovative Antibacterial Correctors for Cystic Fibrosis Targeting the Lung Microbiome with a Multifunctional EffectMaria Grazia Martina, Filomena Sannio, Emmanuele Crespan, et al.
Pharmaceutics|February 25, 2023
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-<i>d</i>]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma MultiformeFederica Poggialini, Chiara Vagaggini, Annalaura Brai, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2016
A cascade screening approach for the identification of Bcr-Abl myristate pocket binders active against wild type and T315I mutantMarco Radi, Ralf Schneider, Anna Lucia Fallacara, et al.
Biochemical Pharmacology|June 11, 2008
Selective targeting of the HIV-1 reverse transcriptase catalytic complex through interaction with the "primer grip" region by pyrrolobenzoxazepinone non-nucleoside inhibitors correlates with increased activity towards drug-resistant mutantsSamantha Zanoli, Sandra Gemma, Stefania Butini, et al.
European Journal of Medicinal Chemistry|April 29, 2014
New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitorsValeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2018
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatmentAlessio Molinari, Anna Lucia Fallacara, Salvatore Di Maria, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2011
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cellsMarco Radi, Chiara Brullo, Emmanuele Crespan, et al.
Chemmedchem|July 2, 2013
Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agentsCristina Tintori, Ilaria Laurenzana, Francesco La Rocca, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Nature Communications|February 27, 2016
Impact of ribonucleotide incorporation by DNA polymerases β and λ on oxidative base excision repairEmmanuele Crespan, Antonia Furrer, Marcel Rösinger, et al.
Chemmedchem|October 13, 2011
N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a scaffold for the synthesis of inhibitors of Bcr-AblFederica Arioli, Stella Borrelli, Francesco Colombo, et al.
Chemmedchem|May 31, 2022
Towards Innovative Antibacterial Correctors for Cystic Fibrosis Targeting the Lung Microbiome with a Multifunctional EffectMaria Grazia Martina, Filomena Sannio, Emmanuele Crespan, et al.
Pharmaceutics|February 25, 2023
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-<i>d</i>]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma MultiformeFederica Poggialini, Chiara Vagaggini, Annalaura Brai, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2016
A cascade screening approach for the identification of Bcr-Abl myristate pocket binders active against wild type and T315I mutantMarco Radi, Ralf Schneider, Anna Lucia Fallacara, et al.
Biochemical Pharmacology|June 11, 2008
Selective targeting of the HIV-1 reverse transcriptase catalytic complex through interaction with the "primer grip" region by pyrrolobenzoxazepinone non-nucleoside inhibitors correlates with increased activity towards drug-resistant mutantsSamantha Zanoli, Sandra Gemma, Stefania Butini, et al.
European Journal of Medicinal Chemistry|April 29, 2014
New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitorsValeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2018
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatmentAlessio Molinari, Anna Lucia Fallacara, Salvatore Di Maria, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2011
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cellsMarco Radi, Chiara Brullo, Emmanuele Crespan, et al.
Chemmedchem|July 2, 2013
Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agentsCristina Tintori, Ilaria Laurenzana, Francesco La Rocca, et al.
Pageof 10